LEXINGTON, Kentucky — The use of digoxin in patients with atrial fibrillation (AF) is being called into question, with the publication of a new study suggesting it is associated with a ...

Mortality, but not hospitalization, went up for patients with AF (but without heart failure) taking digoxin in a large patient cohort, echoing observational findings from the AFFIRM trial.

It’s time to pause on digoxin until studies can assure that it is providing a net benefit to these patients." J Am Coll Cardiol. 2014; 64(7): 660-668. Editorial Standards Reprints & Permissions ...

Digoxin is used to control heart rate in 35–70% of patients with atrial fibrillation (AF). The safety of this drug has been questioned, and previous studies have shown an association between ...

Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20 percent, according to results from the ROCKET AF trial presented at ESC Congress today by Dr ...

Digoxin was independently associated with an increased risk of mortality (hazard ratio [HR], 1.17), vascular death (HR, 1.19), and sudden death (HR, 1.36). There were no interactions between heart ...

Digoxin is commonly used for rate control in AF, but some studies have demonstrated an association with adverse outcomes. There are little data to support the use of digoxin in this patient ...

Nature Reviews Cardiology - Digoxin use is associated with increased mortality in patients with AF regardless of concomitant heart failure Skip to main content Thank you for visiting nature.com.

Digoxin use at the time of enrollment was not a significant independent predictor of mortality, either in patients with HF (hazard ratio [HR], 1.04) or without HF (HR, 1.22). The initiation of ...

Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually. This website is intended ... ‘At the usual £20,000 per QALY ...

The trial in the European Heart Journal of 4,000 patients found digoxin treatment for atrial fibrillation (AF), an abnormal heart rhythm, was linked with a 41% increase in deaths.

SAN FRANCISCO, California — Patients with atrial fibrillation (AF) starting digoxin for the first time showed an independently significant jump in mortality over an average of one year compared with ...